Researchers at the Massachusetts Institute of Technology (MIT) have unveiled a groundbreaking vaccine adjuvant designed to bolster the effectiveness of…
Read More
FDA Grants Priority Review to Roche’s Giredestrant for Early-Stage Breast Cancer, Signaling Potential Paradigm Shift in Adjuvant Therapy
The US Food and Drug Administration (FDA) has accepted priority review of the new drug application (NDA) for Roche’s investigational…
Read MoreYOU MAY HAVE MISSED
